Suzdak Peter David
Insider CIK 1296629 · RNN Chief Executive Officer, Director · AOLS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RNN REXAHN PHARMACEUTICALS, IN | M Exercise deriv | 2018-02-28 | 2018-03-02 | 6,250 | — | $0 | 18,750 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | M Exercise | 2018-02-28 | 2018-03-02 | 6,250 | — | $0 | 22,250 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2018-01-26 | 2018-01-30 | 112,271 | — | $0 | 112,271 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award | 2017-08-16 | 2017-08-16 | 10,000 | $1.99 | $19.9K | 16,000 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2017-01-20 | 2017-01-24 | 250,000 | — | $0 | 250,000 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2017-01-20 | 2017-01-24 | 1,175,000 | — | $0 | 1,175,000 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award | 2016-03-18 | 2016-03-21 | 60,000 | $0.32 | $19.2K | 60,000 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2016-01-28 | 2016-02-01 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2016-01-28 | 2016-02-01 | 411,689 | — | $0 | 411,689 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2015-01-23 | 2015-01-27 | 1,100,000 | — | $0 | 1,100,000 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2014-09-04 | 2014-09-05 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2014-01-12 | 2014-01-14 | 350,000 | — | $0 | 350,000 | SEC↗ |
| AOLS AEOLUS PHARMACEUTICALS, IN | A Award deriv | 2013-05-08 | 2013-05-10 | 75,000 | — | $0 | 75,000 | SEC↗ |
| RNN REXAHN PHARMACEUTICALS, IN | A Award deriv | 2013-02-04 | 2013-02-06 | 1,200,000 | — | $0 | 1,200,000 | SEC↗ |
| AOLS AEOLUS PHARMACEUTICALS, IN | A Award deriv | 2012-10-09 | 2013-03-06 | 11,250 | — | $0 | 11,250 | SEC↗ |
| AOLS AEOLUS PHARMACEUTICALS, IN | A Award deriv | 2012-07-11 | 2013-03-06 | 11,250 | — | $0 | 11,250 | SEC↗ |
| AOLS AEOLUS PHARMACEUTICALS, IN | A Award deriv | 2012-03-20 | 2013-03-06 | 11,250 | — | $0 | 11,250 | SEC↗ |
| AOLS AEOLUS PHARMACEUTICALS, IN | A Award deriv | 2011-11-07 | 2013-03-06 | 11,250 | — | $0 | 11,250 | SEC↗ |
| AOLS AEOLUS PHARMACEUTICALS, IN | A Award deriv | 2011-04-13 | 2013-03-06 | 11,250 | — | $0 | 11,250 | SEC↗ |